Natixis Codexis, Inc. Transaction History

Natixis

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $1.13 Million - $2.97 Million	-135,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$16.97 - $31.93 $1.98 Million - $3.72 Million	116,600 Added 613.68%	135,600 $2.8 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $212,204 - $346,189	8,286 Added 77.34%	19,000 $594,000
Q2 2021 Aug 13, 2021	SELL	$17.48 - $25.46 $216,507 - $315,347	-12,386 Reduced 53.62%	10,714 $243,000
Q1 2021 May 14, 2021	SELL	$18.08 - $28.8 $2.43 Million - $3.87 Million	-134,400 Reduced 85.33%	23,100 $529,000
Q4 2020 Feb 12, 2021	BUY	$11.7 - $23.41 $408,330 - $817,009	34,900 Added 28.47%	157,500 $3.44 Million
Q3 2020 Nov 12, 2020	SELL	$11.21 - $13.82 $396,834 - $489,228	-35,400 Reduced 22.41%	122,600 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$9.8 - $12.77 $1.26 Million - $1.64 Million	128,300 Added 431.99%	158,000 $1.8 Million
Q1 2020 May 14, 2020	SELL	$8.78 - $18.6 $445,145 - $943,020	-50,700 Reduced 63.06%	29,700 $331,000
Q4 2019 Feb 14, 2020	BUY	$13.12 - $17.06 $404,096 - $525,448	30,800 Added 62.1%	80,400 $1.29 Million
Q3 2019 Nov 13, 2019	BUY	$12.75 - $19.01 $632,400 - $942,896	49,600 New	49,600 $680,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.